BioSpace News Archive

United Therapeutics Corporation announced that James Edgemond, Chief Financial Officer and Treasurer, will provide an overview and update on the company’s business during a fireside chat session at the Jefferies Healthcare Conference in New York City.

Researchers have identified certain patients with pancreatic cancer who may be more likely to benefit from combination treatment regimens consisting of immunotherapy and chemotherapy.

Taiho Oncology, Inc. announced today updated results of the Phase 2 FOENIX-CCA2 trial of futibatinib, confirming results observed in an earlier analysis. The trial was conducted in patients with locally advanced or metastatic unresectable intrahepatic (inside the liver) cholangiocarcinoma (iCCA) harboring FGFR2 gene rearrangements including fusions.

Nearly 90% of oncologists said they experience emotional exhaustion at work, and more than two-thirds said they experience additional symptoms of burnout, such as cynicism, detachment and feeling unaccomplished or ineffective, according to new research released from Cardinal Health Specialty Solutions in the eleventh edition of Oncology Insights, a biannual research-based report series analyzing the views of oncologists nationwide.

Kintara Therapeutics, Inc. announced that the Company received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC granting the Company’s request for a 180-day extension to regain compliance with Nasdaq’s minimum bid price requirement under Nasdaq Listing Rule 5550.

Medidata, a Dassault Systèmes company, presented new research on predicting cytokine release syndrome (CRS) resulting from longitudinal CAR T-cell therapy (CAR T) at the American Society for Clinical Oncology (ASCO) Annual Meeting being held June 3-7 in Chicago.

Medline announced a new version of its Optifoam® Gentle EX Foam Dressing.

The global benzyl alcohol market size is expected to reach USD 87.1 Million in 2030 and register a revenue CAGR of 4.3% over the forecast period, according to a latest report by Reports and Data.

The global industrial biotechnology market size is expected to reach USD 852.55 Billion in 2030 and register a revenue CAGR of 9.9% over the forecast period, according to the latest report by Reports and Data.

Smart Meter, continues to lead the way in remote blood glucose monitoring (RBGM) for diabetes because of its ease of use and its superior cellular-enabled devices that deliver immediate, robust data